Oscar Health (OSCR) Jumps 4.8% as Firm Issues Higher Price Target
In its initial coverage on the stock, Stephens & Co. gave Oscar Health Inc. (NYSE:OSCR) a price target of $17 alongside an “equal weight” rating.
Oscar Health Inc. (OSCR)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Thrive Capital Joshua Kushner | 6,343,617 | $120,084,670 | 25.01% | |
| 2. | Citadel Investment Group Ken Griffin | 4,287,208 | $81,156,848 | +114% | 0.01% |
| 3. | Farallon Capital Thomas Steyer | 3,639,000 | $68,886,270 | +147% | 0.28% |
| 4. | 3,417,200 | $64,687,596 | +68% | 0.01% | |
| 5. | 2,512,100 | $47,554,053 | +30% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.86 | 100,000 | $1,685,980.00 | 6,343,617 | 2024-11-21 | Filing | |
| $16.97 | 88,395 | $1,499,700.73 | 6,243,617 | 2024-11-20 | Filing | |
| $16.86 | 100,000 | $1,685,980.00 | 6,343,617 | 2024-11-21 | Filing | |
| $16.97 | 88,395 | $1,499,700.73 | 6,243,617 | 2024-11-20 | Filing | |
| $15.97 | 185,790 | $2,966,155.93 | 6,155,222 | 2024-11-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.59 | 1,852 | $30,724.68 | 179,241 | 2025-12-02 | Filing | |
| $16.59 | 23,965 | $397,579.35 | 477,183 | 2025-12-02 | Filing | |
| $16.59 | 7,338 | $121,737.42 | 172,527 | 2025-12-02 | Filing | |
| $16.59 | 25,135 | $416,989.65 | 1,351,034 | 2025-12-02 | Filing | |
| $16.59 | 4,149 | $68,831.91 | 203,450 | 2025-12-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,160,399 | $381,636,353 | 0.01% | |
| 2. | 16,186,352 | $306,407,651 | 0.01% | |
| 3. | 7,429,500 | $140,640,435 | 0.02% | |
| 4. | 5,298,340 | $100,297,576 | 0.05% | |
| 5. | 5,140,000 | $97,300,200 | 0.01% |
News See All
Piper Sandler Confident in Oscar Health's (OSCR) Market Share and Profitability Growth, Sets $404M Minimum 2027 Adjusted EBITDA Expectation
Oscar Health Inc. (NYSE:OSCR) is one of the high short interest stocks to buy right now.
11 High Short Interest Stocks to Buy Right Now
On December 8, Bob Doll, Crossmark Global Investments CEO and CIO, joined CNBC’s ‘Squawk on the Street’ to discuss the latest market trends and his expectations for the Fed.
Oscar Health, Inc. (OSCR): A Bull Case Theory
We came across a bullish thesis on Oscar Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on OSCR.
Here’s Why Oscar Health (OSCR) Traded Down in Q3
Longleaf Partners, managed by Southeastern Asset Management, released its “Small-Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Oscar (OSCR) Soars 22% in Potential ACA Extension
Oscar Health extended its gains for a second day on Monday, jumping 22.33 percent to close at $16.49 apiece as investors took heart from reports that President Donald Trump would implement an extension...
Oscar (OSCR) Needed The Subsidies, Says Jim Cramer
Oscar Health, Inc. (NYSE:OSCR) is a mid-sized healthcare benefits company. It was one of the worst-hit stocks yesterday as the shares closed 17.6% lower.
12 Fresh Stocks Jim Cramer Discussed Along With His Latest Thoughts On Quantum Computing
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer discussed quantum computing stocks and consumer spending.
Oscar Health, Inc. (NYSE:OSCR) Q3 2025 Earnings Call Transcript
Operator: Good morning. My name is Dustin, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's Third Quarter 2025 Earnings Conference Call.
Oscar Health (OSCR) Jumps 7.8% on New Menopause Plan, AI Tools
Oscar Health grew for a second day on Tuesday, adding 7.88 percent to end at $21.77 apiece as investors welcomed its launch of a new menopause health plan and AI tools to support its customers and medical...
Hedge Fund Resource Center Billionaire Hedge Funds
